Bay Area may be at risk from synthetic biology research labs
By Emily Smith Beitiks,
San Jose Mercury News
| 03. 27. 2012
Lawrence Berkeley National Laboratory recently announced a proposal to build a facility in Richmond at which synthetic biology research will be a major focus. This news should give us pause to consider exactly what risks this little-known field poses for the environment and human health.
Last year, molecular biologist Becky McClain was awarded $1.37 million in a whistle-blower suit against the pharmaceutical giant Pfizer after she was fired for raising safety concerns about the lab where she worked. McClain was infected with a genetically engineered virus being researched in her lab. She continues to experience intermittent paralysis and spinal pain, symptoms consistent with the effects of the pathogen.
McClain's story offers an important lesson for assessing a new kind of bioengineering: the rapidly growing field of synthetic biology, which has already been called genetic engineering on steroids.
Synthetic biologists build artificial organisms using the building blocks of life. While techniques vary, the intent is the same: to create life from scratch. Proponents promise extraordinary benefits, from curing diseases to replacing fossil fuels. But the unknowns are as serious as they...
Related Articles
By Keith Casebonne and Jodi Beckstine [with CGS' Katie Hasson], Disability Deep Dive | 07.24.2025
In this episode of Disability Deep Dive, hosts Keith and Jodi explore the complex interplay between disability science, technology, and ethics with guest Katie Hasson, Associate Director at the Center for Genetics and Society. The conversation delves into...
By Angus Liu, Fierce Pharma | 07.22.2025
A brief skirmish between Sarepta Therapeutics and the FDA has ended before escalating into a full-on regulatory clash, as the company has bowed to the agency’s demand.
In a surprising reversal, Sarepta on Monday said it will pause all shipments...
By Lucy Tu, The Atlantic | 07.11.2025
Donald Trump—who is, by his own accounting, “the fertilization president” and “the father of IVF”—wants to help Americans reproduce. During his 2024 campaign, he promised that the government or insurance companies would cover the cost of in vitro fertilization. In...
By Jared Whitlock, Endpoints News | 07.15.2025
Patient groups face a harder and unpredictable path going state-by-state to boost screening for rare but treatable conditions after the Trump administration disbanded a federal advisory committee on newborn screening.
In April, the Advisory Committee on Heritable Disorders in Newborns...